Amifostine: The First Selective-Target and Broad-Spectrum Radioprotector
Top Cited Papers
- 1 June 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 12 (6) , 738-747
- https://doi.org/10.1634/theoncologist.12-6-738
Abstract
Learning Objectives: After completing this course, the reader will be able to: Select appropriate multidisciplinary treatment regimens and cytoprotection for clinical trials for patients with head and neck cancer.Identify radiation toxicity for the head and neck, lung, and pelvic irradiated areas.Describe the cytoprotective effect of amifostine against radiation toxicity. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.comKeywords
This publication has 51 references indexed in Scilit:
- Amifostine reduces side effects and improves complete response rate during radiotherapy: Results of a meta-analysisInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Amifostine: is there evidence of tumor protection?Seminars in Oncology, 2003
- Effects of radiation on normal tissue: consequences and mechanismsThe Lancet Oncology, 2003
- American Society of Clinical Oncology Clinical Practice Guidelinesfor the Use of Chemotherapy and Radiotherapy ProtectantsJournal of Clinical Oncology, 1999
- Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesisNature, 1998
- Thiol WR-1065 and disulphide WR-33278, two metabolites of the drug Ethyol (WR-2721), protect DNA against fast neutroninduced strand breakageInternational Journal of Radiation Biology, 1997
- Alterations in oxygen transport following WR-2721International Journal of Radiation Oncology*Biology*Physics, 1984
- Hypocalcemia and Inhibition of Parathyroid Hormone Secretion after Administration of WR-2721 (a Radioprotective and Chemoprotective Agent)New England Journal of Medicine, 1983
- Interaction of Cultured Mammalian Cells with WR-2721 and Its Thiol, WR-1065: Implications for Mechanisms of RadioprotectionInternational Journal of Radiation Biology, 1983
- Clinical trials of WR-2721 with radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1982